Bivin & Associates’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
CCM
DM
LCM
Bivin & Associates's VTRS Position: Q2 2022 in Review
Bivin & Associates reduced its Viatris (VTRS) stake by 90% in Q2 2022, selling an estimated $4.38K and leaving 44 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #372.
Bivin & Associates first reported a position in VTRS in Q4 2021 and has held it in 3 quarters since. The position peaked at $6K in Q4 2021. 1,011 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.
- Bivin & Associates held 44 shares of Viatris worth $0 as of Q2 2022.
- Bivin & Associates sold 400 Viatris shares in Q2 2022, an estimated $4.38K.
- Viatris made up ﹤0.01% of Bivin & Associates's portfolio in Q2 2022, its #372 holding.
- Bivin & Associates first reported a position in Viatris in Q4 2021 and has held it in 3 quarters since.
- Bivin & Associates's Viatris position peaked at $6K in Q4 2021.
- 1,011 funds tracked by Wall St. Rank held Viatris as of Q2 2022.
Based on Bivin & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.